Expand ALGS Menu
ALGS MENU

ALGS Stock Posts


Upcoming Earnings

ALGS Aligos Therapeutics9.80-0.03 (-0.3%)

Aligos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±25.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.0%. View Expected Move
ALGS #AligosTherapeutics stock declines -14.2% in premarket,

Premarket Decliner

ALGS Aligos Therapeutics14.16-0.23-1.6%

Premarket:12.15-2.01 (-14.2%)

Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH

Globe NewswireThu, 19-Sep 8:00 AM
ALGS #AligosTherapeutics stock increases 9.5% after hours.

After Hours Gainer

ALGS Aligos Therapeutics14.16-0.23-1.6%

After Hours:15.50+1.34 (+9.5%)

Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024

Globe NewswireWed, 18-Sep 5:00 PM
ALGS #AligosTherapeutics stock increases 9.5% after hours.

After Hours Gainer

ALGS Aligos Therapeutics14.16-0.23-1.6%

After Hours:15.50+1.34 (+9.5%)

Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024

Globe NewswireWed, 18-Sep 5:00 PM
Upcoming Earnings

ALGS Aligos Therapeutics0.460.00 (0.0%)

Aligos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±14.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±0.7%. View Expected Move
Upcoming Earnings

ALGS Aligos Therapeutics0.810.00 (0.0%)

Aligos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±12.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±2.7%. View Expected Move
Load Earlier Posts
Market Data Delayed 15 Minutes